RespireRx Pharmaceuticals Inc (fka RSPI)

[ombowstring]

<<<Ombow, Samyang would have to run many clinical trials in Asia, in a similar process to what happens for US and European regulatory approval.>>> Do you know that for a fact? How soon might they bring product to market?

<<<But if Samyang can run their own trials using Cortex's two lead compounds, unfortunately that would greatly diminish Cortex's ability to partner those 2 compounds to other Pharmas for other territories and indications. Perhaps Neuro will chime in on the topic if he's out there.>>> I disagree. Cortex is trying to make a move for Asian markets. All other markets are still in their quiver. Everything is the same as it was yesterday re all other markets.